“Successful Early Rescue With Isatuximab Plus Carfilzomib-Dexamethasone (ISA-KD) in Daratumumab-Refractory Newly Diagnosed Multiple Myeloma (NDMM) Patients With ‘No Washout Period’: A Real-World Clinical Experience in A Case Series and Literature Review”. 2026. Archives of Clinical and Medical Case Reports 10 (1): 1-5. https://fortunejournals.org/ojs/index.php/acmcr/article/view/23020.